| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -8.2e-05 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 7.8e-05 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 7.3e-05 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -2.5e-05 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 6.7e-06 | 1 |